Letko Brosseau & Associates Inc. increased its holdings in Nutrien Ltd. (NYSE:NTR - Free Report) by 8.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,086,940 shares of the company's stock after purchasing an additional 231,323 shares during the period. Nutrien accounts for 2.7% of Letko Brosseau & Associates Inc.'s investment portfolio, making the stock its 12th biggest position. Letko Brosseau & Associates Inc. owned about 0.63% of Nutrien worth $138,056,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Fairway Wealth LLC purchased a new stake in shares of Nutrien in the fourth quarter worth about $27,000. HHM Wealth Advisors LLC boosted its holdings in Nutrien by 331.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 625 shares of the company's stock valued at $28,000 after purchasing an additional 480 shares during the last quarter. Assetmark Inc. boosted its holdings in Nutrien by 1,437.5% in the fourth quarter. Assetmark Inc. now owns 738 shares of the company's stock valued at $33,000 after purchasing an additional 690 shares during the last quarter. Asset Planning Inc purchased a new position in Nutrien in the fourth quarter valued at about $35,000. Finally, Exchange Traded Concepts LLC boosted its holdings in Nutrien by 96.7% in the fourth quarter. Exchange Traded Concepts LLC now owns 846 shares of the company's stock valued at $38,000 after purchasing an additional 416 shares during the last quarter. Hedge funds and other institutional investors own 63.10% of the company's stock.
Nutrien Stock Performance
NTR traded up $0.46 during trading hours on Friday, hitting $57.92. The company's stock had a trading volume of 1,752,913 shares, compared to its average volume of 2,137,646. Nutrien Ltd. has a fifty-two week low of $43.70 and a fifty-two week high of $60.87. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $28.28 billion, a PE ratio of 42.28, a PEG ratio of 1.19 and a beta of 0.79. The company has a 50-day simple moving average of $52.62 and a 200 day simple moving average of $50.27.
Nutrien (NYSE:NTR - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.24). Nutrien had a net margin of 2.62% and a return on equity of 6.81%. The business had revenue of $4.67 billion during the quarter, compared to analyst estimates of $5.16 billion. During the same quarter in the prior year, the business earned $0.46 earnings per share. The firm's revenue was down 5.4% compared to the same quarter last year. As a group, sell-side analysts expect that Nutrien Ltd. will post 3.72 EPS for the current year.
Nutrien Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, July 18th. Investors of record on Monday, June 30th will be paid a dividend of $0.545 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $2.18 annualized dividend and a yield of 3.76%. Nutrien's dividend payout ratio is currently 203.74%.
Analyst Upgrades and Downgrades
A number of research analysts recently commented on the company. Oppenheimer increased their price target on Nutrien from $58.00 to $63.00 and gave the company an "outperform" rating in a report on Tuesday. The Goldman Sachs Group upped their price objective on Nutrien from $53.00 to $59.00 and gave the company a "sell" rating in a research note on Friday, May 9th. Berenberg Bank upped their price objective on Nutrien from $54.00 to $59.00 and gave the company a "buy" rating in a research note on Tuesday, April 15th. Scotiabank restated a "sector perform" rating and set a $62.00 price objective on shares of Nutrien in a research note on Wednesday. Finally, Barclays upped their price objective on Nutrien from $59.00 to $61.00 and gave the company an "equal weight" rating in a research note on Wednesday. Two analysts have rated the stock with a sell rating, six have issued a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Nutrien has an average rating of "Hold" and a consensus price target of $61.44.
Read Our Latest Analysis on Nutrien
Nutrien Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
See Also
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
